US-funded vaccine trial on babies cancelled in Guinea-Bissau after uproar

by | Nov 19, 2026 | Health

US-funded vaccine trial on babies cancelled in Guinea-Bissau after uproar

A proposed clinical trial examining the effects of hepatitis B vaccination in newborns has been terminated in Guinea-Bissau after widespread objections to its design and conduct. The study, which was to involve 14,000 infants at the Bandim Health Project research center, would have provided the vaccine to half of participants while withholding it from the other half, despite World Health Organization recommendations for universal vaccination at birth.

The trial, funded by the US Centers for Disease Control and Prevention with $1.6 million awarded to the University of Southern Denmark in December 2025, aimed to investigate whether the hepatitis B vaccine produces broader health effects beyond preventing infection. Researchers noted that Guinea-Bissau does not routinely offer birth-dose hepatitis B vaccination and planned to study the vaccine’s effects before the country introduces it into its standard immunization schedule. However, critics argued that withholding a proven protective intervention from vulnerable infants in one of the world’s poorest countries raised serious ethical concerns.

Guinea-Bissau’s government imposed restrictions on hepatitis B vaccine trials involving children in January and maintained that prohibition through October. Health Minister Quinhin Nantote expressed surprise and outrage upon learning from media reports that the trial might proceed without government authorization. The WHO representative in Guinea-Bissau emphasized that withholding a vaccine used safely for more than 30 years across more than 115 countries would be unethical, particularly given that nearly a fifth of Guinea-Bissau’s population carries hepatitis B, a virus that causes chronic infection in infants at high risk of death through liver complications.

On 19 October, Guinea-Bissau’s Judicial Police searched the Bandim Health Project facilities and seized a batch of hepatitis B vaccines. The University of Southern Denmark stated that the trial had never begun, no participants had been enrolled, and no vaccinations had been administered. The dispute occurred amid broader changes to US vaccine policy under the Trump administration and Health Secretary Robert F. Kennedy Jr., who has previously expressed skepticism about vaccines.

Article Attribution | Read More at Article Source

Article summary produced by Claude AI